Unpublished Pharma Patent Applications database | PharmaPlus Consultancy

Have an account? Login

Privacy Policy

Please read the following privacy policy carefully, because by accessing and using the Unpublished Pharma Patent Applications database (including searching the database, reviewing licensing opportunities as well as submitting any information to the database) you agree to our Privacy Policy.

1. Information collection

Unpublished Pharma Patent Applications database subscribers
PharmaPlus Consultancy understands the sensitive nature of the information contained on Unpublished Pharma Patent Applications and we respect the privacy and confidentiality of all of our subscribers. When you subscribe to use the Unpublished Pharma Patent Applications database, we collect your name, address, e-mail address, title and organization. If your application is approved we assign you a user name and password.All information you submit during your subscription process is kept for internal purposes only.
The Unpublished Pharma Patent Applications database website uses Google Analytics.

Licensing opportunity profiles
On Unpublished Pharma Patent Applications as a non-profit research organization you have the possibility to publish your own licensing opportunities information. For any information that is submitted to us, we also track the IP address of the user (which is used for security reasons and internal purposes only).
Licensing opportunity information is usually reviewed by an editor before they are publicly available on the website. PharmaPlus Consultancy reserves the right to exclude or otherwise edit any information submitted to its website.

2. Use of information

Unpublished Pharma Patent Applications database subscribers
Personal information about the Unpublished Pharma Patent Applications subscribers (such as name, postal address, e-mail, phone number) are used for internal purposes only. By submitting such information, you agree that we may contact you by phone, post, e-mail or fax to keep you informed about your subscription, as well as about any information which may be relevant for you as a subscriber.
Information collected with a statistics tool but no personal information (such as the name of the user) is used for internal purposes (access statistics and analysis).

Licensing opportunity profiles
In the Unpublished Pharma Patent Applications database certain information is conveyed for the purpose of partnering licensing opportunities with potential licensees. If you choose to list technology on Unpublished Pharma Patents Applications, your contact information including name, title, organization, phone and email may accompany the description of your technology that is reviewed by subscribers of the Unpublished Pharma Patent Applications database.

3. Use of cookies

In certain cases, we use what are known as "cookies" (small text file that is stored on a user's computer for record-keeping purposes.). You can configure your browser to display a warning before cookies are saved. You can also choose to dispense with personal cookies and the advantages that they offer. If you do so, however, you will not be able to use certain services.

4. Use of Google Analytics - Statement

"This website uses Google Analytics, a web analytics service provided by Google, Inc. ("Google"). Google Analytics uses "cookies", which are small pieces of text sent to your browser by a website you visit. Cookies are placed on your computer, to help the website analyze how users use the site. The information generated by the cookie about your use of the website (including your IP address) will be transmitted to and stored by Google on servers in the United States. Google will use this information for the purpose of evaluating your use of the website, compiling reports on website activity for website operators and providing other services relating to website activity and internet usage. Google may also transfer this information to third parties where required to do so by law, or where such third parties process the information on Google's behalf. Google will not associate your IP address with any other data held by Google. You may refuse the use of cookies by selecting the appropriate settings on your browser, however please note that if you do this you may not be able to use the full functionality of this website. By using this website, you consent to the processing of data about you by Google in the manner and for the purposes set out above."

5. Security

PharmaPlus Consultancy has taken steps to prevent unauthorized access and use of the Unpublished Pharma Patent Applications database. However, no method of transmission over the internet, or method of electronic storage, is 100% secure. Therefore, while we strive to use commercially acceptable means to protect your personal information, we cannot guarantee its absolute security.

6. Legal Disclaimer

PharmaPlus Consultancy may disclose Information when required by law or in the good faith belief that such action is necessary in order to conform to the edicts of the law or comply with a legal process served on us.

7. Notification of Changes

Our Privacy Policy may change from time to time. We will post those changes in this privacy statement.

8. Applicable Law

By visiting the Unpublished Pharma Patent Applications database you agree that the laws of The Netherlands, without regard to principles of conflict of laws, will govern this Privacy Policy and any dispute of any sort that might arise between you and PharmaPlus Consultancy or its affiliates.

9. Contact information

PharmaPlus Consultancy BV
Botterwijnseweg 9
1272 EG Huizen
The Netherlands

Phone: +31 (35) 5243315
Fax: +31 (35) 5231500

E-mail: bakker@pharmaplus.nl
www.pharmaplus.nl

10. Publication Privacy Policy

These Terms of Use were published on June 1st, 2014.

Terms Of Use

Please read the following terms and conditions (“Terms of Use”) carefully, because by accessing and using the Unpublished Pharma Patent Applications database (including searching the database, reviewing licensing opportunities as well as submitting any information to the database) you agree to these Terms of Use.

1. Owner

The Unpublished Pharma Patent Applications database is property of and managed by PharmaPlus Consultancy BV, Huizen, The Netherlands. Database subscription agreements are made between the subscriber and PharmaPlus Consultancy BV (PharmaPlus Consultancy) . These Terms of Use are also binding for all Unpublished Pharma Patent Applications’ distribution partners.

2. Publishing of licensing opportunities by non-profit organizations

Adding and updating licensing opportunities for which patent applications have been filed but not published to the Unpublished Pharma Patent Applications database is completely free of charge for non-profit-organizations. PharmaPlus Consultancy reserves the right to exclude or otherwise edit any information submitted to its databases. All licensing opportunity profiles will be reviewed prior to activation.

3. Extent of Available Information

The amount of licensing opportunities and additional information available in our database may vary from day to day. We do our best to increase the extent of the available information and its accuracy. However, we do not guarantee a minimum number of available licensing opportunities, nor the completeness or accuracy of any licensing opportunity published in the database. PharmaPlus Consultancy cannot be held liable for any information available or missing from the database.

4. Subscriber Identification and Password

Upon the subscriber's acceptance of these Terms of Use, PharmaPlus Consultancy will review the registration information and may issue a unique user ID and password to a qualified subscriber. PharmaPlus Consultancy shall reserve the right to determine the qualifications of the subscriber at its sole discretion. The user ID and password are exclusively for the subscriber's use and for the use of no other person. The subscriber is solely responsible for maintaining the confidentiality of the subscriber's password, and for any and all use and access to the Unpublished Pharma Patent Applications database that occurs under subscriber's account. Subscriber agrees to immediately notify PharmaPlus Consultancy of any unauthorized use of subscriber's ID and Password or account or any other breach of security.

5. Use of information

The subscriber agrees that any downloaded content will be used for internal purposes only. Particularly, data harvesting will not be allowed. Furthermore, no data can be made available to third parties. No part of this database and/or website may be reproduced or transmitted in any form or by any means, electronically, mechanically, by photocopying, by recording or otherwise, without prior permission from PharmaPlus Consultancy.

6. Extent of use

Subscriptions to the Unpublished Pharma Patent Applications date are not restricted but intended for reasonable usage. The "unlimited" access a subscriber gets to the database does not constitute the right to systematically download all available information in the database. PharmaPlus Consultancy has the right to block or cancel an account if PharmaPlus Consultancy deems that a subscriber has exceeded the limit of normal usage. Any use of automated data collecting software is strictly prohibited.

7. License and Site Access

PharmaPlus Consultancy grants you a limited license to access and make personal use of this site but not to download (other than page caching) or modify it, or any portion of it, except with express written consent of PharmaPlus Consultancy. This site or any portion of this site, including any printed materials of the same, may not be reproduced, duplicated, copied, sold, resold, visited, or otherwise exploited for any commercial purpose without express written consent from PharmaPlus Consultancy. This license does not include any resale or commercial use of this site or its contents or any derivative use of this site or its contents. Site Access will automatically terminate if you do not comply with the terms of the Terms of Use.

8. Subscriptions & Pricing

The prices of the subscriptions are valid for one (1) license/person for the corresponding time period (see also "Automatic Renewal" below). All terms described in this document also apply for site licenses (multiple users).

We keep the right to vary or increase the prices of the subscriptions. Price increases for auto-recurring payments will be announced by e-mail at least six weeks prior to the renewal of the subscription. If a subscriber does not agree on the new pricing, the subscription can be cancelled according to the terms described under "Cancellation of Subscription".

9. Automatic Renewal

Unless you cancel your database subscription, subscription based on an annual cycle will be automatically renewed for the same duration. One month prior to the renewal of the subscription you will receive an invoice per e-mail. Please make sure you have a current e-mail address registered in our administration.

10. Cancellation of Subscription

A subscription can be cancelled up to 30 days before the current subscription period ends. You can cancel your subscription by sending us an e-mail (see "Contact information" below). If you cancel a recurring subscription, the subscription remains active until the end of the period for which the last payment has been made.
If you cancel a subscription by e-mail, you will receive an e-mail notification once the subscription has been cancelled. If you do not receive such a notification within 48 hours after cancellation, it must be assumed that we did not receive the e-mail. In this case please contact us again.

11. Refund of payments

PharmaPlus Consultancy does not refund any payments after cancellation of the subscription. If a subscription is cancelled, no further payments will be charged in the future.

12. Expired Subscriptions

After a subscription expires, the account is no longer available to the user.

13. No Warranties

The Unpublished Pharma Patent Applications database, including but not limited to the exchanges and any information presented on the exchanges, are presented “as is” and PharmaPlus Consultancy makes no warranties, express or implied, regarding the member organizations’ involvement or participation. PharmaPlus Consultancy does noet represent or warrant that the information provided on the exchanges regarding invention descriptions or search profiles has been validated nor does PharmaPlus Consultancy represent or warrant that the information is accurate.

14. Links

PharmaPlus Consultancy may provide links to other world wide web sites or resources. PharmaPlus Consultancy does not endorse and is not responsible for any data, software or other content available from such sites or resources. The user acknowledges and agrees that PharmaPlus Consultancy shall not be liable, directly or indirectly, for any damage or loss relating to User's use of or reliance on such data, software or other content.

15. Liability

In no event shall PharmaPlus Consultancy be liable for any damages, direct or indirect or special or consequential (including negligence), lost profits or lost opportunities resulting from or related to the use of the Unpublished Pharma Patent Applications database. We shall exert our best effort to provide you with the highest availability of database services. We are, however, dependent on external parties and cannot provide any guarantee as to availability or accuracy. THE USER AGREES TO BE RESPONSIBLE FOR ANY CLAIMS ARISING OUT OF ANY USER s BREACH OF THE TERMS OF USE.

16. Assignment

The user may not assign or transfer the user's rights under the Terms of Use. PharmaPlus Consultancy may assign all rights and liabilities under the Terms of Use to a subsidiary, affiliate or successor to all or a substantial part of its business and assets without the user's consent. Subject to the foregoing, the Terms of Use will inure to the benefit of and be binding upon the successors and permitted assigns of the parties.

17. Contact information

PharmaPlus Consultancy BV
Botterwijnseweg 9
1272 EG Huizen
The Netherlands

Phone: +31 (35) 5243315
Fax: +31 (35) 5231500

E-mail: bakker@pharmaplus.nl
www.pharmaplus.nl

18. Copyright

All content on the Unpublished Pharma Patent Applications website, including text, graphics, logos, button icons, images, audio clips, video clips, digital downloads, data compilations, and software, is the property of PharmaPlus Consultancy or its content suppliers and protected by international copyright laws. The compilation of all content on this site is the exclusive property of PharmaPlus Consultancy and protected by international copyright laws. All software used on this site is the property of PharmaPlus Consultancy or its software suppliers and protected by international copyright laws.

19. Site Policies, Modification, and Severability

PharmaPlus Consultancy reserves the right to make changes to our site, policies, and these Terms of Use at any time. If any of these conditions shall be deemed invalid, void, or for any reason unenforceable, that condition shall be deemed severable and shall not affect the validity and enforceability of any remaining conditions.

20. Changes to Terms of Use

PharmaPlus Consultancy reserves the right to revise, amend, or modify these Terms of Use at any time and in any manner. If we make material changes to this terms, we will notify you by means of a notice by e-mail.

21. Applicable Law

By visiting the Unpublished Pharma Patent Appliations database, you agree that the laws of The Netherlands, without regard to principles of conflict of laws, will govern these Terms of Use and any dispute of any sort that might arise between you and PharmaPlus Consultancy or its affiliates.

22. Publication Terms of Use

These Terms of Use were published on June 1st, 2014.